Photoactivatable ('caged') pharmacological agents have revolutionized neuroscience but the palette of available ligands is limited. We describe a general method for caging tertiary amines using an unconventional quaternary ammonium linkage that is chemically stable and elicits a desirable red-shift in activation wavelength. A photoactivatable nicotine (PA-Nic) prepared using this strategy could be uncaged via 1-or 2-photon excitation, making it useful for optopharmacology experiments to study nicotinic acetylcholine receptors (nAChRs) in different experimental preparations and spatiotemporal scales.
Photoactivatable ('caged') compounds are essential for modern biology and remain the only tools available for modulation of native proteins with high spatiotemporal resolution. The development of new photoactivatable compounds that are chemically stable and activatable with 1-or 2-photon illumination remains an important application of organic chemistry to the biosciences. The ability to uncage ligands for glutamate and γ-aminobutyric acid (GABA) receptors enabled seminal 'optopharmacology' studies on the biophysics and subcellular location of functional proteins within complex biological environments [1] [2] [3] . Caged ligands targeting other receptors are rare, however, which has prevented precise examination of additional protein classes. We developed a general strategy for preparing photoactivatable drugs through alkylation of tertiary nitrogen atoms to form photolabile quaternary linkages. The resulting photoactivatable nicotine (PA-Nic) exhibits ideal chemical and spectroscopic properties for interrogating endogenous nicotinic acetylcholine receptors (nAChRs) in brain tissue.
Many pharmacological agents cannot be caged using standard strategies because they lack obvious attachment sites (e.g., CO 2 H, OH, NH) for photolabile groups. Four examples of 'uncageable' drugs include nAChR agonists nicotine (1) and PNU-282,987 (2), the opioid fentanyl (3) , and the selective serotonin reuptake inhibitor escitalopram (4, Fig. 1a) . A shared feature of these compounds is a tertiary nitrogen, a common motif in many pharmacological agents. We envisioned a general caging strategy involving covalent attachment of a coumarin [4] [5] [6] photolabile group to form a quaternary ammonium salt. This approach has been employed by chemists to create photoactivatable tertiary amines including polymer initiators 7 , amino acids 8 , mustards 9 , and tamoxifen 10 , but has never been used in a biological context. We initially applied this strategy to nicotine (1), alkylating with coumarin 5 to yield photoactivatable nicotine (PANic, 6; Fig. 1b) . PA-Nic releases nicotine upon UV illumination (365 nm) with a photochemical quantum yield (Φ pc ) of 0.74% (Fig. 1c, Supplementary Fig. 1a ; Supplementary Note), and shows excellent dark stability in aqueous solution (Fig. 1d) . Formation of the quaternary center at the 4-position of the coumarin elicits an unexpected ~15 nm red-shift in absorption maxima of the coumarin cage in PA-Nic (λ max = 404 nm, Fig. 1e ), an excellent match for LED or laser light sources centered near 400 nm. We then applied this strategy to prepare quaternary ammonium photoactivatable derivatives of drugs 2-4, which also gave clean photoconversion ( Supplementary Fig. 1b-d , Supplementary Note) with similar Φ pc , dark stability, and redshifted absorbance maxima ( Supplementary Fig. 1e-g ). We confirmed that the shift in λ max was due to presence of the quaternary center ( Supplementary Fig. 1h ,i) and determined the major and minor byproducts as coumarins 12 and 13, respectively ( Supplementary Fig. 1j ).
With the generality of this caging strategy established, we focused on PA-Nic (6), due to nicotine's high selectivity for nAChRs and the societal and therapeutic significance of this molecule. We combined brain slice electrophysiology with epi-illumination flash photolysis to test the utility of PA-Nic and compare this compound to the known caged nicotine based on noncovalent complexes of ruthenium bis(bipyridine) (RuBi-Nic, 14, Supplementary Fig. 2a ). 11 We prepared mouse brain slices containing the medial habenula (MHb), whose neurons express high levels of nAChRs 12 , co-release ACh and glutamate 13 , and regulate affective behavior and nicotine withdrawal 14 ( Supplementary Fig. 2b-d ). Light flashes (1 s) evoked robust nicotinic currents when PA-Nic (80 µM) was superfused or applied locally via pressure ejection during voltage clamp recordings of MHb neurons (Fig. 1f) . Photolysis of RuBi-Nic with a longer light dose (470 nm; 15 s) elicited a substantially smaller nicotinic current (Supplementary Fig. 2e ).
RuBi-Nic often appeared unstable when applied to brain slices via superfusion, resulting in uncontrollable/irreversible inward currents in the absence of light flashes (Supplementary Fig. 2f ). In contrast to RuBi-Nic, PA-Nic photolysis does not occur with blue (470 nm) or green (560 nm) light flashes (100 ms, 0.06 mW/mm 2 ; Supplementary Fig. 2g ) enabling the use of other fluorophores or light-activated effectors.
Given the substantial improvement in performance over the existing RuBi-Nic, we further characterized PA-Nic in brain slice optopharmacology experiments. We confirmed that the main photochemical by-product of PA-Nic photolysis (12) was inert at nAChRs ( Supplementary Fig.   2h ,i). PA-Nic itself exhibited no antagonist properties at nAChRs, and our preparations of PANic were devoid of free nicotine ( Supplementary Fig. 2j,k) . Fig. 2m ).
Finally, we measured the reversal potential of flash-activated currents by eliciting responses at holding potentials from -80 mV to 0 mV (Supplementary Fig. 2n ). Inward currents activated by photolysis reversed at approximately +2 mV ( Supplementary Fig. 2o ), a characteristic feature of nAChRs.
Native nAChRs in brain slices are typically studied with bulk superfusion or pressure ejection of agonists. Unfortunately, bulk superfusion over-emphasizes the long-term effects of the drug (e.g., desensitization) and pressure ejection is limited by the difficulty associated with applying multiple drug concentrations to the same neuron while maintaining a stable recording.
We tested whether photoactivation of PA-Nic would overcome these challenges. Epiillumination light flashes elicited responses that increased in amplitude with increasing flash energy ( Fig. 1g,h ) and flash duration (Fig. 1i,j) , with 1 s flashes typically eliciting the largest currents. Light-evoked release of nicotine allowed generation of complete photochemical doseresponse relations in neurons, an advantage over application of single drug concentrations.
Caged pharmacological agents (e.g., glutamate, GABA) can be used to modulate action potential firing by precisely controlling ligand concentrations in brain slices with light. We tested whether PA-Nic superfusion and epi-illumination photolysis could be used during current clamp recordings to drive action potential firing via nAChR activation. Using a restricted field stop aperture ( Supplementary Fig. 2k ), we constrained the light flash to different ventral MHb subregions 15 during current clamp recordings from neurons in the VI subregion (Fig. 1k) . Brief flashes (33 ms) transiently enhanced firing when nicotine was uncaged over (within 0-60 µm, xy plane, location (i)) the recorded neuron, but elicited no change in firing when nicotine was uncaged over the VC (~100 µm, xy plane, location (ii)) or VL subregion (~200 µm, xy plane, location (iii)) (Fig. 1k,l) . Two-way repeated-measures ANOVA of treatment (2; baseline vs.
flash) x location (3; (i), (ii), (iii)) showed significant main effects of treatment [F(1,9)=21.07, We tested the utility of PA-Nic under 2-photon (2P) activation to further probe the spatiotemporal precision of PA-Nic photolysis and determine whether the compound could be used in conjunction with 2-photon laser scanning microscopy (2PLSM). Slices were superfused with PA-Nic (100 µM) and photostimulation (720 nm) at multiple perisomatic locations evoked strong and repeatable inward currents (Supplementary Fig. 3a) . Such currents could be evoked at wavelengths between 700 nm and 880 nm ( Supplementary Fig. 3b,c) , consistent with the properties of the coumarin caging moiety 4, 6 . Mecamylamine superfusion significantly decreased the 2-photon uncaging response amplitudes (pre-mec: 11.06 ± 0.9 pA; post-mec: 8.56 ± 1.2 pA; n=11; p=0.008, paired t-test), and additional experiments using blockers of excitatory transmission ruled out any role for ionotropic glutamate receptors (data not shown). Importantly, the relatively narrow 2P-wavelength sensitivity of PA-Nic (<900 nm) circumvents cross-talk with many common fluorophores.
Next, we studied functional nAChRs in specific cellular compartments using 1-photon laser flash photolysis of PA-Nic. Using 2PLSM to visualize neuronal somata and dendrites, laser pulses (405 nm, ~1 µm spot diameter) were positioned adjacent to the soma during voltage clamp recordings. After confirming that moderate laser powers (1-2.5 mW, 50 ms) do not activate inward currents in the absence of PA-Nic ( Supplementary Fig. 3d,e) , we identified suitable stimulation parameters by first measuring the relationship between evoked inward currents versus laser power ( Supplementary Fig. 3f,g ) and versus pulse duration ( Supplementary Fig. 3h,i) . nAChR currents evoked by PA-Nic photolysis were antagonized by mecamylamine (Fig. 2a) . nAChR activation could also be elicited from ventral tegmental area (VTA) neuronal somata using a local perfusion procedure ( Supplementary Fig. 3j,k) . VTA neurons exhibit modest nAChR expression compared to MHb neurons, demonstrating that PANic can be used to study aspects of cholinergic transmission in multiple cell-types.
Next, we estimated the spatial resolution of PA-Nic uncaging in MHb neurons. nAChR responses fell to 50% of their initial value at approximately 4.5 µm from the soma (Fig. 2b,c) .
We next determined whether functional nAChRs are present in dendrites of MHb neurons by uncaging nicotine at various dendritic locations. We found that nAChRs were functionally expressed in most subcellular locations, but the response amplitudes were greater near the soma and proximal dendrite compartments compared to distal dendrites (Fig. 2d,e ). Nicotine appears in arterial blood rapidly (~10 s) in response to a puffed or vaped bolus 16 , and the close proximity (~20 µm) of neurons to capillaries implies that nicotine interacts with native nAChRs within seconds after reaching the brain. These results showcase the temporal and spatial precision afforded by laser flash photolysis of PA-Nic, which provides a pharmacokinetically relevant exposure paradigm superior to pressure ejection pulses.
Finally, we used PA-Nic epi-illumination and laser flash photolysis to study the pharmacology and cell biology of nAChR up-regulation, a key feature of human nicotine dependence. Chronic nicotine treatment results in up-regulation of nAChR function in MHb neurons 15 , including ChAT(+) neurons ( Supplementary Fig. 4a-d ), but it is unknown whether this up-regulation reflects a numerical increase in surface receptors or a shift in nAChR sensitivity. We used PA-Nic to generate a photochemical dose-response curve for nAChR currents in ChAT(+) MHb neurons from control and nicotine-treated mice, and found that chronic nicotine increased the pharmacological efficacy of acutely-applied nicotine without affecting its potency (Fig. 2f,g ). This suggests the main action of chronic nicotine in MHb neurons may be to increase the overall number of functional surface receptors, without strongly affecting receptor sensitivity. Next, we used flash photolysis of PA-Nic combined with 2PLSM
to examine how chronic nicotine exposure affects nAChR function in different cellular compartments. To do so, we examined laser flash-evoked nicotinic responses on somata as well as dendrites at various distances from the soma. Uncaging responses were enhanced in nicotine-exposed neurons, compared to control neurons, on both somata and dendrites ( Fig. 2h,i ). These data reveal that chronic nicotine exposure has a sensitizing effect on MHb neurons across the cell, potentially allowing ACh or nicotine to modulate key neuronal processes, such as action potential firing and dendritic integration. PA-Nic has thus afforded, to our knowledge, the first direct interrogation of postsynaptic nAChR plasticity mediated by chronic nicotine.
In summary, we have developed a strategy for preparing photoactivatable derivatives of previously uncagable drugs. The photoactivatable nicotine (PA-Nic, 6) developed using this approach efficiently releases nicotine (Fig. 1b, Supplementary Fig. 1a )-a specific nAChR agonist-making it advantageous over CNB-caged carbachol 17 , which activates all acetylcholine receptor types. PA-Nic can be activated by relatively short wavelength 1-photon (<470 nm) or 2- supervised all aspects of the work.
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measure the photochemical quantum yield (Fig. 1c) , the loss of PA-Nic (6) was monitored using a 4.6 × 150 mm Kinetex C18 column (Phenomenex) with a 5-95% gradient of CH 3 CN in H 2 O containing constant 0.1% v/v TFA. To examine the release of pharmacological agents 2-4 and coumarin byproducts from compounds 7-10 ( Supplementary Fig. 1 ), samples were run on tandem liquid chromatography-mass spectrometry (LC-MS) using an Agilent 1200 LC-MS system equipped with autosampler, diode array detector, and mass spectrometry detector using a 4.6 × 150 mm Gemini NX-C18 column with a 5-95% (Supplementary Fig. 1a,d ) and 5-50%
( Supplementary Fig. 1b,c 1.21), we determined the photon flux (I) = 3.57 × 10 -7 ein/min·cm 2 . For the conversion of PANic (6) to nicotine (1), the samples were irradiated and a small aliquot (50 µL) was placed in an amber glass high recovery HPLC vial. These samples were analyzed by HPLC as described above. The photochemical quantum yield (Φ PC , mol/ein) was determined by fitting a plot of HPLC peak integral signal (S) vs. irradiation time to a one-phase exponential decay described by equation 1:
where S 0 = signal prior to irradiation, t = irradiation time (min), S t = signal at time t, I = irradiation (ein/min·cm 2 ), and σ = decadic extinction coefficient (in units of cm 2 /mol; 1000-fold higher than the ε value with units of M -1 cm -1 based on cuvette geometry). For the conversion of compound 6 to compound 1, we determined Φ pc = 0.74% (Fig. 1c) . Coumarin-based cages have found broad utility in release of small molecule modulators of biological activity [4] [5] [6] [21] [22] [23] [24] [25] [26] [27] . We note the Φ pc value for 6 is lower than coumarin caged molecules releasing better leaving groups such as carboxylates and phosphates 4, 6, 21, 22 , but similar to the Φ pc value of a 7-aminocoumarin caged compound releasing an amine via a carbamate linkage 6 . For other caged compounds, the photochemical quantum yield was determined by illumination with 405 nm LED (LOCTITE CL20 flood array) using 6 as a standard ( Supplementary Fig. 1e , Supplementary Note).
Reagents for Neurobiology Experiments. QX-314, CNQX, and D-AP5 were obtained from Tocris. RuBi-nicotine was obtained from Abcam. Acetylcholine (ACh), mecamylamine (mec), atropine, picrotoxin, and all other chemicals without a specified supplier were obtained from Sigma.
Mice. An animal study protocol pertaining to this study (#IS00003604) was reviewed and approved by the Northwestern University Institutional Animal Care and Use Committee.
Procedures also followed the guidelines for the care and use of animals provided by the National Expression of tdTomato in MHb ChAT(+) neurons was confirmed in these mice via immunohistochemistry and confocal microscopy ( Supplementary Fig. 2d ). All studies were restricted to male mice, age 8-24 wks.
Chronic Nicotine Treatment. Mice were treated with nicotine via drinking water as previously implantation. 15 Therefore, we validated this result with the nicotine drinking water method in C57BL/6 WT mice ( Supplementary Fig. 4a,b) before conducting PA-Nic uncaging experiments coupled with chronic nicotine studies on ChAT-IRES-Cre::Ai14 mice ( Supplementary Fig. 4c,d and Fig. 2f-i Fig. 2b) Tissue was blocked and transferred to a slicing chamber containing ice-cold ACSF, supported by a small block of 4% agar. Bilateral 250 µm-thick slices containing the MHb were cut on a Leica VT1000S and transferred into a holding chamber with ACSF equilibrated with 95% O 2 /5% CO 2 .
Slices were incubated at 34 °C for 15-30 minutes prior to electrophysiological recording.
UV-Vis Nicotine Uncaging. Brain slices were transferred to a recording chamber being continuously superfused at a rate of 1.5-2.0 mL/min with oxygenated 32 °C recording solution.
The recording solution contained (in mM): 124 NaCl, 2. Some experiments involved recording inward currents following pressure ejection application of drug (ACh or PA-Nic) to the recorded cell using a drug-filled pipette, which was moved to within 20-40 µm of the recorded neuron using a micromanipulator. Using a Picospritzer (Parker Hannifin), a pressure ejection dispensed drug (dissolved in the same superfusion medium used on the slice) onto the recorded neuron. Ejection volume, duration, and ejection pressure varied depending on whether a short (ms) or long (s) pulse was required. The change in amplitude between the baseline and the peak was measured. Atropine (1 µM) was present in the superfusion medium when using ACh to prevent activation of muscarinic ACh receptors. To prevent stray light from prematurely uncaging nicotine inside the drug pipette, the field stop aperture on the microscope was restricted, and the drug pipette was retracted from the cell immediately following the application. Fig. 3d,e) . No such currents were detected at <2.5 mW ( Supplementary   Fig. 3d,e) , so laser pulses in this study did not exceed 2 mW.
PA-Nic was applied (40-80 µM in 5 mL) via superfusion to the slice using a recirculating perfusion system to conserve compound. Due to lower levels of nAChR expression compared to
MHb, a higher concentration of PA-Nic (1 mM) was required to uncage appreciable nicotinic currents in VTA neurons. For such studies, local perfusion was performed; a glass pipette with a large diameter (30-40 µm) was back-filled with PA-Nic (1 mM) dissolved in ACSF, and was connected to a pressure ejection device. The PA-Nic-filled pipette was maneuvered to within ~50 µm of the recorded neuron and perfusion was triggered with a constant, low pressure (1-2 psi) ( Supplementary Fig. 3k, inset) . Prairie View 5 software was used to select spots in the field of view for focal uncaging of nicotine via 405 nm laser light flashes. Typical flash durations were 10-50 ms (unless otherwise stated), which were selected following an analysis of the relationship between pulse duration and nAChR activation (Supplementary Fig. 3h,i) . Immunohistochemistry and Confocal Microscopy. Mice were anesthetized with sodium pentobarbital (100 mg/kg, i.p.) and transcardially perfused with 10 mL of heparin-containing phosphate buffered saline (PBS) followed by 30 mL of 4% paraformaldehyde. Brains were dissected, postfixed in 4% paraformaldehyde overnight at 4 °C, and dehydrated in 30% sucrose.
2-Photon Nicotine
Coronal brain slices (50 µm) were cut on a freezing/sliding microtome (SM2010R; Leica). MHbcontaining slices were stained using the following procedure. Slices were first permeabilized for 2 min via incubation in PBST (0.3% Triton X-100 in PBS), followed by a 60 min incubation in blocking solution (0.1% Triton X-100, 5% horse serum in Tris-buffered saline (TBS)). Primary antibodies used in this study were as follows: goat anti-ChAT (Millipore; cat# AB144P), rabbit anti-DsRed (Clontech; cat# 632496). Primary antibodies were diluted in blocking solution (antiChAT at 1:100, anti-DsRed at 1:500). Slices were incubated in primary antibodies overnight at 4 °C. Three 5 min washes in TBST (0.1% Triton X-100 in TBS) were done before transferring slices to secondary antibodies for a 60-min incubation at room temperature. Secondary antibodies, diluted 1:500 in blocking solution, were as follows: anti-goat Alexa 488 (Invitrogen; cat# A11055), anti-rabbit Alexa 647 (Invitrogen; cat# A31573). Slices were washed as before, mounted on slides, and coverslipped with Vectashield. Staining in the MHb was imaged as previously described 12 with a Nikon A1 laser-scanning confocal microscope.
For pharmacological experiments involving animal models, sample sizes were selected based on prior similar studies 12, 15 , and mice of the appropriate age (8-24 wks) were randomly (informal randomization) chosen for assignment to specific experimental groups. For some studies involving recordings from neurons derived from mice treated with nicotine or control drinking water, the experimenter was blind to the treatment during data collection. Outlier data points were removed from data sets via the ROUT method (Q=1%) as previously described 33 .
Data Availability. The data that support the findings of this study, if not explicitly contained within the paper, Supplementary Information, or Supplementary Note, are available from the corresponding authors upon reasonable request. 
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